Stockscreener 앱 받기
645.55
1.97%
12.50
시간 외 거래:
645.55
전일 마감가:
$633.05
열려 있는:
$635.76
하루 거래량:
352.18K
Relative Volume:
0.60
시가총액:
$51.65B
수익:
$4.04B
순이익/손실:
$985.66M
주가수익비율:
53.75
EPS:
12.01
순현금흐름:
$774.34M
1주 성능:
-0.81%
1개월 성능:
+21.34%
6개월 성능:
+42.58%
1년 성능:
+31.28%
1일 변동 폭
$634.69
$648.55
1주일 범위
$632.57
$652.08
52주 변동 폭
$356.14
$688.12
아이덱스 래버러토리스 Stock (IDXX) Company Profile
명칭
Idexx Laboratories Inc
전화
(207) 556-0300
주소
ONE IDEXX DRIVE, WESTBROOK, ME
IDXX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
|
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
|
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
아이덱스 래버러토리스 Stock (IDXX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-05 | 재확인 | BTIG Research | Buy |
| 2025-07-01 | 개시 | Jefferies | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-12-04 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2023-08-02 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-07-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2022-05-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-08 | 개시 | Atlantic Equities | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-02-17 | 개시 | Barclays | Overweight |
| 2019-09-09 | 개시 | Goldman | Neutral |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2018-11-02 | 재확인 | BofA/Merrill | Buy |
| 2018-05-07 | 재확인 | Stifel | Buy |
| 2018-01-16 | 개시 | Piper Jaffray | Overweight |
| 2017-08-23 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | 업그레이드 | CL King | Neutral → Buy |
| 2017-02-03 | 다운그레이드 | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 재개 | BofA/Merrill | Neutral |
| 2016-08-16 | 재확인 | Stifel | Buy |
| 2016-08-03 | 업그레이드 | Northcoast | Sell → Neutral |
| 2016-07-20 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-19 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-01 | 개시 | CL King | Neutral |
| 2016-03-21 | 재확인 | Stifel | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2015-10-29 | 재확인 | Stifel | Buy |
| 2015-08-28 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 재확인 | Stifel | Buy |
| 2015-07-23 | 재확인 | Canaccord Genuity | Buy |
모두보기
아이덱스 래버러토리스 주식(IDXX)의 최신 뉴스
Is IDEXX Laboratories Inc. Forming a Bottom PatternWeekly Risk Summary & Community Supported Trade Ideas - mustnews.co.kr
Idexx Labs Surges to Top 500 Volume Despite 0.18% Slide as Analysts Back Buy Ratings - AInvest
Watch for Bullish Crossover in IDEXX Laboratories Inc.July 2025 Movers & Fast Moving Market Watchlists - beatles.ru
National Veterinary Associates Welcomes Brian McKeon to Board of Directors - The Malaysian Reserve
Live Chart Scan Detects Wedge Pattern in IDEXX Laboratories Inc.2025 Buyback Activity & AI Based Trade Execution Alerts - newsyoung.net
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, Morgan Stanley Analyst Says - MarketBeat
Published on: 2025-08-17 06:07:39 - beatles.ru
Earnings Not Telling The Story For IDEXX Laboratories, Inc. (NASDAQ:IDXX) After Shares Rise 25% - simplywall.st
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Aardvark Therapeutics, Inc. (AARD) - The Globe and Mail
Why IDEXX Laboratories Inc. stock attracts strong analyst attentionJuly 2025 WrapUp & Daily Risk Controlled Trade Plans - thegnnews.com
How IDEXX Laboratories Inc. stock performs during market volatilityJuly 2025 Retail & Verified Momentum Stock Ideas - sundaytimes.kr
IDEXX Laboratories: A Powerhouse in Veterinary Diagnostics with Strong Q2 2025 Outperformance and Strategic Innovation - AInvest
IDEXX Laboratories 2025 Investor Day: Jay Mazelsky Presentation - AInvest
Transcript : IDEXX Laboratories, Inc.Analyst/Investor Day - MarketScreener
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $745 to $785 - 富途牛牛
IDEXX Laboratories: Morgan Stanley raises PT to $765, maintains Overweight rating. - AInvest
Idexx Laboratories Inc Insider Sold Shares Worth $263,814, According to a Recent SEC Filing - MarketScreener
Is IDEXX Laboratories Inc. forming a double bottomJuly 2025 Patterns & Real-Time Stock Movement Alerts - thegnnews.com
Insider Sell: Michael Erickson Sells Shares of IDEXX Laboratories Inc (IDXX) - GuruFocus
IDEXX Laboratories Executive Vice President Erickson Sells Shares on August 12, 2025. - AInvest
IDEXX Laboratories : Investor Day 2025 presentation - MarketScreener
There's Reason For Concern Over IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Massive 26% Price Jump - 富途牛牛
IDEXX Laboratories Executive Vice President Hunts Nimrata sells 1200 shares. - AInvest
Idexx Labs executive Hunt sells $787k in shares - Investing.com
Idexx Labs executive Hunt sells $787k in shares By Investing.com - Investing.com Canada
Piper Sandler Raises IDEXX Laboratories (IDXX) PT to $700, Cites Strong Q2 Results - Yahoo Finance
IDEXX Laboratories EVP buys, sells shares in single day. - AInvest
IDEXX Laboratories' 15min chart shows MACD, KDJ death crosses. - AInvest
Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today - Yahoo Finance
A Closer Look at IDEXX Laboratories's Options Market Dynamics - Benzinga
IDEXX Laboratories' 15min chart: RSI Overbought, KDJ Death Cross triggered. - AInvest
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $700 From $510, Maintains Neutral Rating - MarketScreener
IDEXX Laboratories: Piper Sandler Raises PT to $700 from $510 - AInvest
Idexx Laboratories Inc Insider Sold Shares Worth $5,279,893, According to a Recent SEC Filing - MarketScreener
Is Now An Opportune Moment To Examine IDEXX Laboratories, Inc. (NASDAQ:IDXX)? - 富途牛牛
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Short Interest Drops in IDEXX Laboratories Inc. After RallyLow Capital High Return Stock Plans Reviewed - beatles.ru
IDEXX Executives Make Major Stock Trades on August 6 - AInvest
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$5.28 Million in Common Stock - 富途牛牛
IDEXX Labs Volume Plummets 28% as Veterinary Diagnostics Stock Slides to 256th in U.S. Trading Activity Rankings - AInvest
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $675.00 at JPMorgan Chase & Co. - MarketBeat
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance
IDEXX’s Healthy Streak Outpaces The Pack In Animal Care - Finimize
How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs - MSN
IDEXX Laboratories shares rise 3.10% intraday after Rothschild & Co Redburn raised price target to $670. - AInvest
IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
IDEXX Laboratories Q2 2025 Earnings Call: Strong Revenue and EPS Growth Amid Challenges - AInvest
BTIG Boosts Idexx Laboratories Price Target to $785 Amid Strong Q2 Earnings - AInvest
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $745 - 富途牛牛
아이덱스 래버러토리스 (IDXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아이덱스 래버러토리스 주식 (IDXX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hunt Nimrata | Executive Vice President |
Aug 12 '25 |
Option Exercise |
244.16 |
1,226 |
299,344 |
18,033 |
| Hunt Nimrata | Executive Vice President |
Aug 11 '25 |
Sale |
656.53 |
1,200 |
787,840 |
16,807 |
3.82%
자본화:
|
볼륨(24시간):